CVS Health Corporation (CVS)
CVS Health - Q2 Earnings Are A Referendum On Future Of Company
CVS has transformed from a retail pharmacy to a complex healthcare conglomerate, but its stock price has remained stagnant over the past decade. The Medicare Advantage business, once seen as a growth engine, has become less profitable, leading to management shakeups and activist investor intervention. Despite a short-term recovery in 2025, CVS faces ongoing challenges: declining retail, regulatory threats to PBM, and uncertain Medicare Advantage profitability.
CVS Health Corporation (CVS) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching CVS Health (CVS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
CVS Up on Medicare Advantage Strength: Is It a Buy Before Q2 Earnings?
CVS stock surges nearly 50% in 2025, aided by strong Q1 results, raised guidance and easing Medicare regulation risks.
Here's Why CVS Health (CVS) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
CVS Health (CVS) Stock Falls Amid Market Uptick: What Investors Need to Know
CVS Health (CVS) closed at $66.6 in the latest trading session, marking a -4.28% move from the prior day.
Will CVS Health (CVS) Beat Estimates Again in Its Next Earnings Report?
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Brokers Suggest Investing in CVS Health (CVS): Read This Before Placing a Bet
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to CVS Health (CVS). This makes it worthwhile to examine what the stock has in store.
CVS drops Lilly's Zepbound
CNBC's Angelica Peebles reports on news regarding CVS.
Tracking the 3 Best Dividend Stocks in 2025
With the first half of 2025 wrapped up, now feels like as good a time as any to check in with the top-performing dividend plays and see how the stage is set for the rest of the year.
Will CVS Health's Formulary Move Boost Its Weight Management Program? (Revised)
CVS adds Wegovy to its top formularies and bolsters its Weight Management program, aiming to expand access while cutting costs.
